Incidence and risk factors for acute kidney injury following autologous stem cell transplantation for multiple myeloma
Incidence and risk factors for acute kidney injury following autologous stem cell transplantation for multiple myeloma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Incidence and risk factors for acute kidney injury following autologous stem cell transplantation for multiple myeloma have?
Incidence and risk factors for acute kidney injury following autologous stem cell transplantation for multiple myeloma has 31 citations in the OpenAlex counts ScholarIQ stores.
When was Incidence and risk factors for acute kidney injury following autologous stem cell transplantation for multiple myeloma published?
Incidence and risk factors for acute kidney injury following autologous stem cell transplantation for multiple myeloma has 2019 year in the ScholarIQ index.
What is the open-access status of Incidence and risk factors for acute kidney injury following autologous stem cell transplantation for multiple myeloma?
Incidence and risk factors for acute kidney injury following autologous stem cell transplantation for multiple myeloma has gold oa status in the ScholarIQ index.
What is the DOI of Incidence and risk factors for acute kidney injury following autologous stem cell transplantation for multiple myeloma?
The DOI for Incidence and risk factors for acute kidney injury following autologous stem cell transplantation for multiple myeloma is on the source record.
What is the PMID of Incidence and risk factors for acute kidney injury following autologous stem cell transplantation for multiple myeloma?
The PMID for Incidence and risk factors for acute kidney injury following autologous stem cell transplantation for multiple myeloma is on the source record.
What is the OpenAlex record for Incidence and risk factors for acute kidney injury following autologous stem cell transplantation for multiple myeloma?
The OpenAlex for Incidence and risk factors for acute kidney injury following autologous stem cell transplantation for multiple myeloma is on the source record.